5 November 2023
RNZ's Kim Hill discusses the results of the Malaghan Institute's phase 1 clinical trial.
Michele Leggott / Dr Robert Weinkove / Prof Carl June
Results have been released for Malaghan Institute's ground-breaking CAR T-cell cancer therapy trial, and they are promising.
The therapy reprogrammes a patient's own immune cells to recognise and kill cancer.
Discussing the treatment and trial are Professor Carl June from the University of Pennsylvania who pioneered the therapy and Dr Robert Weinkove, who leads Malaghan's CAR T-cell programme.
They are joined by writer and poet Michele Leggott, who is twelve months into the trial, for an update on her progress.
Related articles
New Zealand has a chance to lead in next-generation cancer treatments
11 March 2026
Award celebrates international collaboration that sparked landmark cancer discovery
10 March 2026
CAR T-cell therapy: 5-part video series
25 February 2026
Momentum is everything: advancing CAR T-cell research for future trials and treatments
25 February 2026
A ground-breaking cancer treatment is within reach – but only if New Zealand acts now
12 February 2026
Homegrown Hope - Stuff's series on CAR T-cell therapy
11 February 2026